3-Methoxyhexane | 54658-01-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-Methoxyhexane
• CAS: 54658-01-4
• 化学式: C₇H₁₆O
• 分子量: 116.2
• InChiKey: QNJRNZBXNCPKHQ-UHFFFAOYSA-N

物化性质

• 熔点：
  -95.35°C (estimate)
• 沸点：
  117.3°C (estimate)
• 密度：
  0.7684 (estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  8
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  (4E)-3-methoxyhexa-1,4-diene 以100%的产率得到
  参考文献：
  名称：

  KIRMSE, W.;VAN, CHIEM, PHAM;HENNING, P. -G., TETRAHEDRON, 1985, 41, N 8, 1441-1451

  摘要：

  DOI：

文献信息

• [EN] HYDROXAMIC ACID DERIVATIVES AS LPXC INHIBITORS FOR THE TREATMENT OF BACTERIAL INFECTIONS<br/>[FR] DÉRIVÉS D'ACIDE HYDROXAMIQUE UTILISÉS COMME INHIBITEURS DE LPXC POUR LE TRAITEMENT D'INFECTIONS BACTÉRIENNES
  申请人：NOVARTIS AG

  公开号：WO2014160649A1

  公开（公告）日：2014-10-02

  This invention pertains generally to antibacterial organic compounds of Formula I as described herein, and pharmaceutical compositions containing such compounds. In certain aspects, the invention pertains to treating infections caused by Gram-negative bacteria using these compounds and compositions.

  这项发明通常涉及如本文所述的一般抗菌有机化合物I的公式，以及含有这些化合物的药物组合物。在某些方面，该发明涉及使用这些化合物和组合物治疗由革兰氏阴性细菌引起的感染。
• Method for the production of beta-ketonitriles
  申请人：Vogelbacher Uwe Josef

  公开号：US20100105903A1

  公开（公告）日：2010-04-29

  The present invention relates to a process for preparing β-ketonitriles of the general formula I in which R 1 is, inter alia, C 1 -C 12 -alkyl, C 2 -C 12 -alkenyl, C 2 -C 12 -alkinyl, C 3 -C 8 -cycloalkyl, C 3 -C 8 -cycloalkyl-C 1 -C 4 -alkyl, phenyl-C 1 -C 4 -alkyl, phenoxy-C 1 -C 4 -alkyl or benzyloxy-C 1 -C 4 -alkyl; R 2 is, inter alia, hydrogen, C 1 -C 12 -alkyl, C 2 -C 12 -alkenyl, C 2 -C 12 -alkinyl, C 3 -C 8 -cycloalkyl, C 3 -C 8 -cycloalkyl-C 1 -C 4 -alkyl, phenyl, phenyl-C 1 -C 4 -alkyl, phenoxy-C 1 -C 4 -alkyl or benzyloxy-C 1 -C 4 -alkyl, which comprises reacting a nitrile of the formula II in which R 1 has one of the meanings given above with a carboxylic ester of the formula III in which R 2 has one of the meanings given above and R 3 is C 1 -C 12 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 3 -C 8 -cycloalkyl, C 3 -C 8 -cycloalkyl-C 1 -C 4 -alkyl, phenyl-C 1 -C 4 -alkyl, phenoxy-C 1 -C 4 -alkyl or benzyloxy-C 1 -C 4 -alkyl, where the reaction is carried out in the presence of a potassium alkoxide and at least 80% of the nitrile of the formula II are added to the reaction under reaction conditions.

  本发明涉及一种制备一般式I的β-酮腈的方法，其中R1是C1-C12-烷基、C2-C12-烯基、C2-C12-炔基、C3-C8-环烷基、C3-C8-环烷基-C1-C4-烷基、苯基-C1-C4-烷基、苯氧基-C1-C4-烷基或苄氧基-C1-C4-烷基；R2是氢、C1-C12-烷基、C2-C12-烯基、C2-C12-炔基、C3-C8-环烷基、C3-C8-环烷基-C1-C4-烷基、苯基、苯基-C1-C4-烷基、苯氧基-C1-C4-烷基或苄氧基-C1-C4-烷基。该方法包括将具有上述给定含义之一的一般式II的腈与具有上述给定含义之一的一般式III的羧酸酯反应，其中R3是C1-C12-烷基、C1-C4-烷氧基-C1-C4-烷基、C3-C8-环烷基、C3-C8-环烷基-C1-C4-烷基、苯基-C1-C4-烷基、苯氧基-C1-C4-烷基或苄氧基-C1-C4-烷基，在存在钾醇和至少80%的一般式II的腈被加入到反应中，并在反应条件下进行。
• Triptycene analogs
  申请人：——

  公开号：US20020091163A1

  公开（公告）日：2002-07-11

  This invention provides analogs of triptycene which are useful as anticancer drugs, as well as for other uses. The potency of these compounds is in a similar magnitude as daunomycin, a currently used anticancer drug. Each compound of the invention produces one or more desired effects (blocking nucleoside transport, inhibiting nucleic acid or protein syntheses, decreasing the proliferation and viability of cancer cells, inducing DNA fragmentation or retaining their effectiveness against multidrug-resistant tumor cells).

  这项发明提供了三苯乙烯的类似物，可用作抗癌药物，以及其他用途。这些化合物的效力与目前使用的抗癌药达诺霉素相当。该发明的每种化合物都产生一个或多个期望的效果（阻断核苷酸转运、抑制核酸或蛋白质合成、降低癌细胞的增殖和存活能力、诱导DNA断裂或保持其对多药耐药肿瘤细胞的有效性）。
• [EN] METHOD FOR PRODUCING ESTERS OF HOMOVANILLIC ACID<br/>[FR] PROCÉDÉ DE PRODUCTION D'ESTERS D'ACIDE HOMOVANILLIQUE
  申请人：SYMRISE AG

  公开号：WO2021219192A1

  公开（公告）日：2021-11-04

  The present invention primarily relates to a method for producing a compound of formula (I) and/or a physiologically acceptable salt thereof from vanillylmandelic acid and/or a physiologically acceptable salt thereof. The present invention further relates to the simultaneous use of one or more iodide salt(s) or hydrate(s) thereof, one or more reducing agent(s), one or more inorganic and/or organic acid(s) other than phosphonic acid, and methanol and/or a physiologically acceptable salt thereof or an alcohol of formula (II) as defined herein and/or a physiologically acceptable salt thereof for converting vanillylmandelic acid and/or a physiologically acceptable salt thereof into a compound of formula (I) and/or a physiologically acceptable salt thereof or into a compound of formula (III) as defined herein and/or a physiologically acceptable salt thereof.

  本发明主要涉及一种从香草酸和/或其生理上可接受的盐制备公式(I)化合物的方法，同时使用一种或多种碘化物盐或其水合物、一种或多种还原剂、一种或多种磷酸以外的无机和/或有机酸、甲醇和/或其生理上可接受的盐或本文所定义的公式(II)的醇和/或其生理上可接受的盐，将香草酸和/或其生理上可接受的盐转化为公式(I)化合物和/或其生理上可接受的盐，或者转化为本文所定义的公式(III)化合物和/或其生理上可接受的盐。
• CYCLOALKYLPHENYL SUBSTITUTED CYCLIC KETOENOLS
  申请人：Fischer Reiner

  公开号：US20090305891A1

  公开（公告）日：2009-12-10

  The disclosure relates to novel cycloalkylphenyl-substituted cyclic ketoenols of the formula (I) in which J, X, Y, m and CKE are as defined above, to processes and intermediates for their preparation and to their use as pesticides and/or herbicides. Moreover, the disclosure relates to selective herbicidal compositions comprising, firstly, the cycloalkylphenyl-substituted cyclic ketoenols and, secondly, a crop plant compatibility-improving compound. The disclosure furthermore relates to increasing the activity of crop protection compositions comprising compounds of the formula (I) by adding ammonium or phosphonium salts and, if appropriate, penetrants.

  该披露涉及到具有以下结构的新型环烷基苯基取代的环状酮烯醇（I）的公式，其中J、X、Y、m和CKE的定义如上所述，以及它们的制备过程和中间体，以及它们作为杀虫剂和/或除草剂的用途。此外，该披露涉及包括第一部分为环烷基苯基取代的环状酮烯醇和第二部分为作物植物相容性改进化合物的选择性除草剂组合物。该披露还涉及通过添加铵盐或膦盐以及必要时渗透剂来增加公式（I）化合物的作物保护组合物的活性。